dabigatran etexilate

Poland

Drugs containing this active substance

  • DAROXOMB

    The medicine is used in adults to prevent the formation of blood clots in the brain (stroke) and other blood vessels (in the case of atrial fibrillation and additional risk factors) and for the treatment and prevention of recurrence of clots in the veins of the legs and lungs. In children, the medicine is used to treat clots and prevent their recurrence.

    Form: capsules, hard

    Active substance Dosage
    dabigatran etexilate 150 mg

    ATC: B01AE07

    Manufacturer: Galenicum Health S.L.U., SAG MANUFACTURING, S.L.U.

  • DAXANLO

    In adults, it is used to prevent the formation of blood clots in the veins after hip or knee replacement surgery. In children, this medicine is used to treat blood clots and to prevent their recurrence.

    Form: capsules, hard

    Active substance Dosage
    dabigatran etexilate 75 mg

    ATC: B01AE07

    Manufacturer: Krka d.d., Novo mesto

  • DAXANLO

    Daxanlo is used in adults to prevent strokes and blood clots (in atrial fibrillation) and in the treatment and prevention of recurrence of blood clots in the leg and lung veins. In children, it is used for the treatment and prevention of recurrence of blood clots.

    Form: capsules, hard

    Active substance Dosage
    dabigatran etexilate 150 mg

    ATC: B01AE07

    Manufacturer: Krka d.d., Novo mesto

  • DAXANLO

    The medicine is used in adults to prevent blood clots after hip or knee replacement surgery, to prevent strokes in people with atrial fibrillation, and to treat and prevent the recurrence of blood clots in the leg veins and lungs. In children, it is used to treat blood clots and to prevent their recurrence.

    Form: capsules, hard

    Active substance Dosage
    dabigatran etexilate 110 mg

    ATC: B01AE07

    Manufacturer: Krka d.d., Novo mesto

  • GRIBERO

    The medicine is used in adults to prevent the formation of blood clots in the veins after hip or knee replacement surgery. In children, it is used to treat blood clots and to prevent their recurrence.

    Form: capsules, hard

    Active substance Dosage
    dabigatran etexilate 75 mg

    ATC: B01AE07

    Manufacturer: Lek Pharmaceuticals d.d., Pharmadox Healthcare Ltd., Salutas Pharma GmbH

  • GRIBERO

    The medicine is used in adults to prevent blood clots after hip or knee surgery, to prevent strokes in people with atrial fibrillation, and to treat and prevent the recurrence of blood clots in the leg and lung veins. In children, the medicine is used to treat blood clots and to prevent their recurrence.

    Form: capsules, hard

    Active substance Dosage
    dabigatran etexilate 110 mg

    ATC: B01AE07

    Manufacturer: Lek Pharmaceuticals d.d., Pharmadox Healthcare Ltd., Salutas Pharma GmbH

  • GRIBERO

    The medicine is used in adults to prevent the formation of blood clots in the brain (stroke) and other blood vessels (in atrial fibrillation), as well as to treat and prevent the recurrence of clots in the veins of the legs and lungs. In children, the medicine is used to treat clots and prevent their recurrence.

    Form: capsules, hard

    Active substance Dosage
    dabigatran etexilate 150 mg

    ATC: B01AE07

    Manufacturer: Lek Pharmaceuticals d.d., Pharmadox Healthcare Ltd., Salutas Pharma GmbH

  • MIREXAN

    In adults, it is used to prevent the formation of blood clots in the veins after hip or knee replacement surgery. In children, this medicine is used to treat blood clots and to prevent their recurrence.

    Form: capsules, hard

    Active substance Dosage
    dabigatran etexilate 86.48 mg

    ATC: B01AE07

    Manufacturer: Biofarm Sp. z o.o. Galenicum Health, S.L.U. SAG Manufacturing S.L.U.

  • MIREXAN

    The medicine is used in adults to prevent blood clots after hip or knee replacement surgery, to prevent strokes in people with atrial fibrillation, and to treat and prevent the recurrence of blood clots in the leg and lung veins. In children, the medicine is used to treat blood clots and prevent their recurrence.

    Form: capsules, hard

    Active substance Dosage
    dabigatran etexilate 126.83 mg

    ATC: B01AE07

    Manufacturer: Biofarm Sp. z o.o. Galenicum Health, S.L.U. SAG Manufacturing S.L.U.

  • MIREXAN

    The medicine is used in adults to prevent strokes and blood clots (in atrial fibrillation) and in the treatment and prevention of blood clots in the veins of the legs and lungs. In children, it is used to treat blood clots and prevent their recurrence.

    Form: capsules, hard

    Active substance Dosage
    dabigatran etexilate 172.95 mg

    ATC: B01AE07

    Manufacturer: Biofarm Sp. z o.o. Galenicum Health, S.L.U. SAG Manufacturing S.L.U.

  • PRABIXAN

    In adults, it is used to prevent the formation of blood clots in the veins following hip or knee replacement surgery. In children, this medicine is used to treat blood clots and to prevent their recurrence.

    Form: capsules, hard

    Active substance Dosage
    dabigatran etexilate 86.48 mg

    ATC: B01AE07

    Manufacturer: Laboratori Fundacio Dau Pharmadox Healthcare Limited

  • PRABIXAN

    The medicine is used in adults to prevent blood clots after hip or knee surgery, to prevent strokes in people with atrial fibrillation, and to treat and prevent the recurrence of blood clots in the leg and lung veins. In children, it is used to treat blood clots and prevent their recurrence.

    Form: capsules, hard

    Active substance Dosage
    dabigatran etexilate 126.83 mg

    ATC: B01AE07

    Manufacturer: Laboratori Fundacio Dau Pharmadox Healthcare Limited

  • PRABIXAN

    The medicine is used in adults to prevent the formation of blood clots in the brain and other vessels (in atrial fibrillation with additional risk) and to treat and prevent the recurrence of clots in the veins of the legs and lungs. In children, it is used to treat clots and prevent their recurrence.

    Form: capsules, hard

    Active substance Dosage
    dabigatran etexilate 172.95 mg

    ATC: B01AE07

    Manufacturer: Laboratori Fundacio Dau Pharmadox Healthcare Limited

  • SIANTA

    In adults, the medicine is used to prevent the formation of blood clots in the veins after hip or knee replacement surgery. In children, it is used to treat blood clots and to prevent their recurrence.

    Form: capsules, hard

    Active substance Dosage
    dabigatran etexilate 75 mg

    ATC: B01AE07

    Manufacturer: Galenicum Health, S.L.U. SAG MANUFACTURING, S.L.U.

  • SIANTA

    Sianta is used in adults to prevent blood clots after hip or knee surgery, to prevent strokes in people with atrial fibrillation, and to treat and prevent the recurrence of blood clots in the leg and lung veins. In children, the medicine is used to treat blood clots and to prevent their recurrence.

    Form: capsules, hard

    Active substance Dosage
    dabigatran etexilate 110 mg

    ATC: B01AE07

    Manufacturer: Galenicum Health, S.L.U. SAG MANUFACTURING, S.L.U.

  • SIANTA

    Sianta is used in adults to prevent strokes and other blood clots in the blood vessels (in atrial fibrillation) and in the treatment and prevention of blood clots in the veins of the legs and lungs. In children, the medicine is used to treat and prevent the recurrence of blood clots.

    Form: capsules, hard

    Active substance Dosage
    dabigatran etexilate 150 mg

    ATC: B01AE07

    Manufacturer: Galenicum Health, S.L.U. SAG MANUFACTURING, S.L.U.

  • TELEXER

    The medicine is used in adults to prevent blood clots after hip or knee surgery, to prevent strokes in people with atrial fibrillation, and to treat and prevent the recurrence of blood clots in the leg and lung veins. In children, it is used to treat blood clots and to prevent their recurrence.

    Form: capsules, hard

    Active substance Dosage
    dabigatran etexilate 126.837 mg

    ATC: B01AE07

    Manufacturer: Gedeon Richter Plc. Gedeon Richter Polska Sp. z o.o.

  • TELEXER

    The medicine is used in adults to prevent strokes and blood clots (in atrial fibrillation) and in the treatment and prevention of recurrence of clots in the veins of the legs and lungs. In children, it is used to treat clots and prevent their recurrence.

    Form: capsules, hard

    Active substance Dosage
    dabigatran etexilate 172.96 mg

    ATC: B01AE07

    Manufacturer: Gedeon Richter Plc. Gedeon Richter Polska Sp. z o.o.

  • TUXANUVA

    In adults, it is used to prevent blood clots in the veins following hip or knee replacement surgery. In children, it is used to treat blood clots and to prevent them from recurring.

    Form: capsules, hard

    Active substance Dosage
    dabigatran etexilate 75 mg

    ATC: B01AE07

    Manufacturer: Pharmadox Healthcare Limited STADA Arzneimittel AG

  • TUXANUVA

    Tuxanuva is used in adults to prevent blood clots after hip or knee replacement surgery, to prevent strokes and clots in other vessels in people with atrial fibrillation, and to treat and prevent the recurrence of clots in the leg and lung veins. In children, it is used to treat clots and prevent their recurrence.

    Form: capsules, hard

    Active substance Dosage
    dabigatran etexilate 110 mg

    ATC: B01AE07

    Manufacturer: Pharmadox Healthcare Limited STADA Arzneimittel AG

  • TUXANUVA

    Tuxanuva is used in adults to prevent the formation of blood clots in the brain and other blood vessels (in atrial fibrillation) and to treat and prevent the recurrence of clots in the veins of the legs and lungs. In children, it is used to treat blood clots and prevent their recurrence.

    Form: capsules, hard

    Active substance Dosage
    dabigatran etexilate 150 mg

    ATC: B01AE07

    Manufacturer: Pharmadox Healthcare Limited STADA Arzneimittel AG

  • WASEDOC

    The medicine is used in adults to prevent blood clots after hip or knee replacement surgery, to prevent strokes and blood clots in blood vessels (in atrial fibrillation with additional risk), and in the treatment and prevention of recurrence of blood clots in the leg and lung veins. In children, it is used to treat blood clots and prevent their recurrence.

    Form: capsules, hard

    Active substance Dosage
    dabigatran etexilate 110 mg

    ATC: B01AE07

    Manufacturer: Terapia S.A., TOWA Pharmaceuticals Europe, S.L.

  • WASEDOC

    Wasedoc is used in adults to prevent the formation of blood clots in the brain and other blood vessels (in atrial fibrillation) and to treat and prevent the recurrence of clots in the veins of the legs and lungs. In children, the medicine is used to treat blood clots and to prevent their recurrence.

    Form: capsules, hard

    Active substance Dosage
    dabigatran etexilate 150 mg

    ATC: B01AE07

    Manufacturer: Terapia S.A., TOWA Pharmaceuticals Europe, S.L.